Small Business Innovation Research Phase IIB Bridge Awards
Page 2

The SBIR program is comprised of three stages: Phase 1 is where small business establish feasibility and technical merit of their proposed area of study, Phase 2 is where these people move forward to research and development efforts in order to advance their technology towards ultimate commercialization, and Phase 3 where they're supposed to have fully commercialized their technology using non-SBIR funds, which would mean they'd have to find a third-party financier.

The NIH has discovered that the small business concerns find it rather hard to move into Phase 3, due to the shortage of third-party funding.

In response, the NIH has developed the SBIR Phase 2B program where they will provide funding to small business concerns in need of such finances.

The NIH will give priority to projects that address one of the following areas: cancer therapeutics, cancer imaging technologies, interventional devices, and in vivo diagnostics, and in vitro and ex vivo cancer diagnostics and prognostics.

The NIH will administer a total amount of $10,000,000 which will be divided into 10 awards.

Eligible applicants for this program are small business concerns who, at the time of award of Phase I and Phase II, meets all of the following criteria:

a) Is organized for profit, with a place of business located in the United States, and operates primarily within the United States and makes a significant contribution to the United States economy by way of payment of taxes or use of American products, materials or labor

b) Is in the legal form of an individual proprietorship, corporation, joint venture, association, trust or cooperative, partnership, or limited liability company

c) Is at least 51% owned by individual(s) who are citizens of, or permanent aliens in, the United States

d) Does not have more than 500 employees.



Small Business Innovation Research Phase IIB Bridge Awards
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Modeling Social Behavior Grant Program
The National Institutes of Health has collaborated with the National Institute of General Medical Sciences (NIGMS) and the National Institute of Mental Health (NIMH) in order to establish the Modeling Social Behavior Grant Program wherein they intend to seek applications for the development and evaluation of innovative theories, as well as computational, mathematical, and engineering approaches that could better our understanding of a human being's social behavior.

---

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---